ImmuneMed, Inc. promises to become a world-trusted company based on creative high-tech intensive research and sound management. Our focus is on human health and welfare in terms of the treatment of incurable or obstinate diseases.
We are developing and exporting diagnostic kits using lateral flow immunochromatographic assay for early detection of acute febrile illnesses such as Scrub typhus, Leptospirosis, Haemorrhagic fever with renal syndrome, Dengue, Salmonella and COVID-19. These kits are able to detect IgM and IgG simultaneously and the reliable accuracy is based on species specific antigens, which are registered as ImmuneMed`s patents. We also have certificates such as ISO13485, KGMP and CE.